Published in Health Business Week, March 5th, 2010
Michael C. Snabes, MD, PhD, BioSante's vice president of clinical development, will give a presentation entitled, "Low Cardiovascular Event Rate in Post-menopausal Women with Increased Cardiac Risk: Findings from the Ongoing Blinded LibiGel (testosterone gel) Cardiovascular and Breast Cancer Safety Study," on Saturday February 20, 2010.
BioSante is in Phase III development of LibiGel for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2010-03-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.